Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | P-BCMA-101 CAR-T cells |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
P-BCMA-101 CAR-T cells are Centyrin-based CAR-T cells targeting B cell maturation antigen (BCMA), which results in immune response against BCMA-positive tumor cells (Blood 2016 128 (22):2127). |
| DrugClasses | TNFRSF17 Immune Cell Therapy 27 |
| CAS Registry Number | NA |
| NCIT ID | C142864 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| P-BCMA-101 CAR-T cells | P-BCMA-101 CAR-T cells | 0 | 1 |
| P-BCMA-101 CAR-T cells + Rimiducid | P-BCMA-101 CAR-T cells Rimiducid | 0 | 0 |